The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Parainfluenza Viruses Diagnostics Market Research Report 2025
Synopsis
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global Human Parainfluenza Viruses Diagnostics market was valued at US$ 531.5 million in 2023 and is anticipated to reach US$ 935.8 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Parainfluenza Viruses Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Parainfluenza Viruses Diagnostics.
Report Scope
The Human Parainfluenza Viruses Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Parainfluenza Viruses Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Parainfluenza Viruses Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene
Segment by Type
HPV Testing
Follow-up HPV Testing
Co-testing
Segment by Application
Diagnostic Centers
Hospitals
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Parainfluenza Viruses Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The global Human Parainfluenza Viruses Diagnostics market was valued at US$ 531.5 million in 2023 and is anticipated to reach US$ 935.8 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Parainfluenza Viruses Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Parainfluenza Viruses Diagnostics.
Report Scope
The Human Parainfluenza Viruses Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Parainfluenza Viruses Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Parainfluenza Viruses Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene
Segment by Type
HPV Testing
Follow-up HPV Testing
Co-testing
Segment by Application
Diagnostic Centers
Hospitals
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Parainfluenza Viruses Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Parainfluenza Viruses Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HPV Testing
1.2.3 Follow-up HPV Testing
1.2.4 Co-testing
1.3 Market by Application
1.3.1 Global Human Parainfluenza Viruses Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Parainfluenza Viruses Diagnostics Market Perspective (2019-2030)
2.2 Human Parainfluenza Viruses Diagnostics Growth Trends by Region
2.2.1 Global Human Parainfluenza Viruses Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Parainfluenza Viruses Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Human Parainfluenza Viruses Diagnostics Market Dynamics
2.3.1 Human Parainfluenza Viruses Diagnostics Industry Trends
2.3.2 Human Parainfluenza Viruses Diagnostics Market Drivers
2.3.3 Human Parainfluenza Viruses Diagnostics Market Challenges
2.3.4 Human Parainfluenza Viruses Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Parainfluenza Viruses Diagnostics Players by Revenue
3.1.1 Global Top Human Parainfluenza Viruses Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Human Parainfluenza Viruses Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Parainfluenza Viruses Diagnostics Revenue
3.4 Global Human Parainfluenza Viruses Diagnostics Market Concentration Ratio
3.4.1 Global Human Parainfluenza Viruses Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Parainfluenza Viruses Diagnostics Revenue in 2023
3.5 Human Parainfluenza Viruses Diagnostics Key Players Head office and Area Served
3.6 Key Players Human Parainfluenza Viruses Diagnostics Product Solution and Service
3.7 Date of Enter into Human Parainfluenza Viruses Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Parainfluenza Viruses Diagnostics Breakdown Data by Type
4.1 Global Human Parainfluenza Viruses Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Type (2025-2030)
5 Human Parainfluenza Viruses Diagnostics Breakdown Data by Application
5.1 Global Human Parainfluenza Viruses Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Parainfluenza Viruses Diagnostics Market Size (2019-2030)
6.2 North America Human Parainfluenza Viruses Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Parainfluenza Viruses Diagnostics Market Size by Country (2019-2024)
6.4 North America Human Parainfluenza Viruses Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Parainfluenza Viruses Diagnostics Market Size (2019-2030)
7.2 Europe Human Parainfluenza Viruses Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Parainfluenza Viruses Diagnostics Market Size by Country (2019-2024)
7.4 Europe Human Parainfluenza Viruses Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Parainfluenza Viruses Diagnostics Market Size (2019-2030)
9.2 Latin America Human Parainfluenza Viruses Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Detail
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Human Parainfluenza Viruses Diagnostics Introduction
11.1.4 Qiagen Revenue in Human Parainfluenza Viruses Diagnostics Business (2019-2024)
11.1.5 Qiagen Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Human Parainfluenza Viruses Diagnostics Introduction
11.2.4 Roche Diagnostics Revenue in Human Parainfluenza Viruses Diagnostics Business (2019-2024)
11.2.5 Roche Diagnostics Recent Development
11.3 Hologic
11.3.1 Hologic Company Detail
11.3.2 Hologic Business Overview
11.3.3 Hologic Human Parainfluenza Viruses Diagnostics Introduction
11.3.4 Hologic Revenue in Human Parainfluenza Viruses Diagnostics Business (2019-2024)
11.3.5 Hologic Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Human Parainfluenza Viruses Diagnostics Introduction
11.4.4 Abbott Laboratories Revenue in Human Parainfluenza Viruses Diagnostics Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Human Parainfluenza Viruses Diagnostics Introduction
11.5.4 BD Revenue in Human Parainfluenza Viruses Diagnostics Business (2019-2024)
11.5.5 BD Recent Development
11.6 Seegene
11.6.1 Seegene Company Detail
11.6.2 Seegene Business Overview
11.6.3 Seegene Human Parainfluenza Viruses Diagnostics Introduction
11.6.4 Seegene Revenue in Human Parainfluenza Viruses Diagnostics Business (2019-2024)
11.6.5 Seegene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
